Market News & Trends
Foster Analytical Services Speed Time to Market for Drug Delivery Formulations
Foster Delivery Science, a business unit for Foster Corporation, recently announced it has added comprehensive in-house laboratory services to expedite the screening of early stage…
Merck KGaA Signs $550 Million Pact With Threshold Pharmaceuticals
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, recently announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to…
Novozymes Wins Innovation Award for Ground-Breaking Half-Life Extension Platform
Novozymes Biopharma, part of Novozymes A/S, recently announced it has received the 2012 Drug Delivery Partnerships (DDP) Technology Innovation award for the company's half-life extension…
OctoPlus Enters Development & Manufacturing Agreement With Ferring Pharmaceuticals
OctoPlus N.V. recently announced a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S, a leading innovative pharmaceutical company. The undisclosed contract…
Catalent Expands Controlled-Release Drug Development & Supply Capabilities
Catalent Pharma Solutions recently announced it is continuing to expand its drug development and delivery capabilities to help customers bring better treatments to patients through…
Encap Drug Delivery Adds New Commercial Product to Portfolio
Encap Drug Delivery, the world's leading contract development and manufacturing organization (CDMO) totally dedicated to liquid and semi-solid (hot melt) filled capsules, recerntly announced the…
New Delivery Platform Discussed at Partnerships Meeting
On January 26, 2012, at the Drug Delivery Partnerships meeting in Las Vegas, a new drug delivery platform was discussed during the session titled Preformulation…
Spectrum Pharmaceuticals to Acquire Worldwide Rights to Market ZEVALIN
Spectrum Pharmaceuticals recently announced it has entered into an agreement to acquire licensing rights to market ZEVALIN (ibritumomab tiuxetan) injection for intravenous use outside the…
Zogenix & Battelle to Collaborate on Advanced Drug Delivery Technology
Zogenix, Inc. and Battelle recently announced a unique collaboration with the objective of advancing the development and commercialization of Zogenix's DosePro drug delivery technology outside…
1/31/2012
Amgen to Buy Micromet for $1.16 Billion Amgen and Micromet, Inc. recently announced the companies have entered into a definitive merger agreement under which Amgen will…
Amgen to Buy Micromet for $1.16 Billion
Amgen and Micromet, Inc. recently announced the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded…
1/24/2012
Dishman Pharmaceuticals & Chemicals Acquires Creapharm Parenterals Switzerland-based Carbogen Amcis AG, a leading pharmaceutical process development and API manufacturing company, recently announced the acquisition of…
Aptalis Pharma Announces NDA Approval of Oral Powder Formulation of Viread
Aptalis Pharma recently announced the US FDA has approved an NDA for Gilead Sciences, Inc.'s Viread (tenofovir disoproxil fumarate) oral powder in combination with other…
Avila Announces Allowance of IND Application for Oral EGFR Mutant-Selective Inhibitor
Avila Therapeutics, Inc. recently announced it has achieved the first milestone in its Epidermal Growth Factor Receptor (EGFR) Mutant-Selective Inhibitor (EMSI) alliance with Clovis Oncology,…
B. Braun Becomes First to Deliver FDA-Approved 2-g Cefazolin
B. Braun Medical Inc. recently announced it received US FDA approval for 2-g Cefazolin for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX…
Dishman Pharmaceuticals & Chemicals Acquires Creapharm Parenterals
Switzerland-based Carbogen Amcis AG, a leading pharmaceutical process development and API manufacturing company, recently announced the acquisition of Creapharm Parenterals, a subsidiary of France-based Creapharm…
Patheon Adds Soft Gel Capsule Capabilities Through New Partnership
Patheon and PROCAPS S.A. recently announced an agreement to provide the pharmaceutical industry a new world-class line of prescription pharmaceutical soft-gel product development and manufacturing…
RaNA Therapeutics Emerges With $20.7 Million Start-Up Financing
RaNA Therapeutics, Inc. recently announced it has completed a $20.7 million round of financing co-led by Atlas Venture, SR One, and Monsanto, with participation of…
Sigma-Aldrich to Acquire BioReliance Corporation for $350 Million
BioReliance, a leading provider of global biopharmaceutical testing services, recently announced it has agreed to be acquired by Sigma-Aldrich Corporation. Avista Capital Partners, the majority…
Ventana Medical Systems & Cell Signaling Technology to Collaborate With Pfizer on Companion Diagnostic
Ventana Medical Systems, Inc., a member of the Roche Group, recently announced it has entered into a collaboration agreement with Pfizer Inc. and license agreement…
